Medication Adherence among Acute Coronary Syndrome Outpatients at Sardjito Hospital in 2019
DOI:
https://doi.org/10.30595/pharmacy.v21i1.17807Keywords:
Adherence, ACS, STEMIAbstract
Worldwide, heart disease accounts for the majority of deaths. One of the indications of coronary illness is Acute Coronary Syndrom (ACS) STEMI. With a prevalence rate of 7.2%, Indonesia still has the highest ACS incidence, and it continues to rise annually. Several factors are involved in reducing the mortality rate of ACS, namely by controlling several risk factors that can reduce the incidence and improve treatment. This study aims to determine the level of adherence to drug use in patients who are registered with new STEMI and outpatients at Sardjito Hospital Yogyakarta. The research method used in this study was non-experimental analytic observational with a retrospective cohort design. Measurement using the Medication Possession Ratio (MPR) method. The study population was patients who were registered for the first ACS diagnosis since January 2017 and followed the course of their treatment until the patient stopped using the drug or the end of observation (31 December 2018). The number of samples obtained according to the inclusion criteria was 495 patients. Adherence to the use of antithrombotic drugs was greater in female patients (82.4%), age < 60 years (88.4%), and patients using combination antithrombotic therapy regimens (81.4%). Statistical significance was shown in the category of gender (Log Rank = 0.046) and treatment regimen (Log Rank = 0.005). However, the age category did not show statistical significance (Log Rank = 0.289). The conclusion of this study is that adherence to the use of antithrombotic drugs in STEMI patients is influenced by gender and therapeutic regimen.
References
Ahmadi M, Lanphear BP. 2022. The impact of clinical and population strategies on coronary heart disease mortality: An assessment of rose’s big idea. BMC Public Health, 22(1), 14.
Amaliah R, Yaswir R, Prihandani T. 2019. Gambaran homosistein pada pasien infark miokard akut di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 8(2), 351.
Antman EM, Braundwald E. 2010. Harrison's Principles of Internal Medicine (17th ed). New South Wales: McGraw Hill.
Astuti A, Maulana. 2018. Faktor risiko infark miokard di Kota Jambi. Jurnal Endurance, 3(1), 82.
Faridi KF, Peterson ED, McCoy LA, Thomas L, Enriquez J, Wang TY. 2016. Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction. JAMA Cardiology, 1, 147–155.
Fernández-Lázaro CI, García-González JM, Adams DP, Fernández-Lázaro D, Mielgo-Ayuso J, Caballero-García A, Canelo JAM. 2019. Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study. BMC Family Practice, 20(1).
Gadkari A, McHorney CA. 2012. Unintentional non-adherence to chronic prescription medications: How unintentional is it really? BMC Health Services Research, 12(1).
Hugtenburg JG, Timmers L, Elders P, Vervloet M, van Dijk L. 2013. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Preference and Adherence, 7, 675-682.
Jin H, Tang C, Wei Q, Chen L, Sun Q, Ma G, Liu N. 2014. Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge. BMC Cardiovascular Disorders, 14(127), 1-9.
Kementerian Kesehatan RI. 2018. Hasil Utama Riskesdas. Kementrian Kesehatan Republik Indonesia. Available from: http://www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/Hasil Riskesdas 2018.pdf [Accessed 10th Mei 2023].
Laranjeira C, Carvalho D, Valentim O, Moutinho L, Morgado T, Tomás C. Querido A. 2023. Therapeutic adherence of people with mental disorders: An evolutionary concept analysis. International Journal of Environmental Research and Public Health, 20(5), 3869.
Merlo A, Troccolo A, Piredda E, Porto I, Ad VG. 2022. Myocardial infarction with non-obstructive coronary arteries: risk factors and associated comorbidities. Frontiers in Cardiovascular Medicine, 9, 895053.
Ramadhani BYS, Rotty LWA, Wantania F. 2013. Gambaran hematologi pada pasein sindroma koroner akut yang dirawat di BLU RSUP Prof. Dr. R.D. Kandou Manado tahun 2010. Journal e-Biomedik, 1, 12-16.
Saleh J. 2021. Women’s heart health is not just about hormones. Nature, 594(7862), S18-S18.
Smeltzer SC, Bare BG. 2013. Buku Ajar Keperawatan Medical Bedah. Jakarta: EGC
Szummer K, Montez-Rath ME, Alfredsson J, Erlinge D, Lindahl B, Hofmann R, Ravn-Fischer A, Svensson P, Jernberg T. 2020. Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: Insights from the SWEDEHEART registry. Circulation, 142 (18), 1700-1708.
Thapa S, Nielsen J. 2021. Association between health literacy, general psychological factors, and adherence to medical treatment among Danes aged 50–80 years. BMC Geriatrics, 21(1).
Tofler GH, Kopel E, Klempfner R, Eldar M, Buckley T, Goldenberg I. 2017. Triggers and timing of acute coronary syndrome. American Journal of Cardiology, 119(10), 1560-1565.
Tumade B, Jim EL, Joseph VFF. 2014. Prevalensi sindrom koroner akut di RSUP Prof. Dr. R. D Kandou Manado Periode 1 Januari 2014. Jurnal e-Clinic, 4 (1), 223-300.
Tuppin P, Neumann A, Danchin N, Peretti DP, Weill A, Ricordeau P, Allemand H. 2010. Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization. Archives of Cardiovascular Diseases, 103(6-7), 363- 375.
Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O'Flaherty M, Krahn M, Capewell S. 2010. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA, 303(18), 1841-7.
Yoon S, Kwan YH, Yap WL, Lim ZY, Phang JK, Loo YX, Low LL. 2023. Factors influencing medication adherence in multi-ethnic Asian patients with chronic diseases in Singapore: A qualitative study. Frontiers in Pharmacology, 14
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
